Search results for "Type 2"

showing 10 items of 1034 documents

Vibriosis in aquaculture. 16th EAFP Conference, Tampere, Finland, 4th September 2013

2014

Aquaculture in brackish and marine water is growing worldwide (FAO, 2014), including new cultured species. Various Vibrio infections occur, and cause significant problems, in fish, crustacean and shellfish (Austin & Austin, 2007. Vibrio anguillarum, V. salmonicida, V. ordalii and V. vulnificus are among the pathogens that lead to the biggest losses in aquaculture all over the world (Toranzo et al. 2005, Sandlund et al., 2010; Sitjà-Bobadilla et al. 2014).

animal structuresIDENTIFICATIONVULNIFICUS BIOTYPE 2STRAINSfungiAqüiculturaPeixos/dk/atira/pure/sustainabledevelopmentgoals/life_below_waterANGUILLA-ANGUILLABacteris patògensINFECTIONEEL FARMPATHOGENSEROVAR-ESDG 14 - Life Below WaterFISHERIESMARINEOUTBREAKSCRASSOSTREA-GIGAS
researchProduct

Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome.

2020

Type 2 diabetes (T2D) is one of the main current threats to human health. Both T2D and its numerous clinical complications are related to mitochondrial dysfunction and oxidative stress. Over the past decade, great progress has been made in extending our knowledge about the signaling events regulated by mitochondria. However, the links among mitochondrial impairment, oxidative stress, autophagy, endoplasmic reticulum (ER) stress, and activation of the inflammasome still need to be clarified. In light of this deficit, we aim to provide a review of the existing literature concerning the complicated crosstalk between mitochondrial impairment, autophagy, ER stress, and the inflammasome in the mo…

autophagyMitochondrial DiseasesInflammasomesEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismMitochondrionmedicine.disease_causeInflammasome03 medical and health sciences0302 clinical medicineEndocrinologyinflammasomemedicineAutophagyAnimalsHumansbusiness.industryEndoplasmic reticulumAutophagyMolecular pathogenesisInflammasomeType 2 diabetesEndoplasmic Reticulum StressCell biologyMitochondriamitochondriaCrosstalk (biology)Oxidative StressDiabetes Mellitus Type 2Unfolded protein responsetype 2 diabetesbusinessOxidative stressmedicine.drugTrends in endocrinology and metabolism: TEM
researchProduct

Harmonic balance analysis of pull-in range and oscillatory behavior of third-order type 2 analog PLLs

2020

The most important design parameters of each phase-locked loop (PLL) are the local and global stability properties, and the pull-in range. To extend the pull-in range, engineers often use type 2 PLLs. However, the engineering design relies on approximations which prevent a full exploitation of the benefits of type 2 PLLs. Using an exact mathematical model and relying on a rigorous mathematical thinking this problem is revisited here and the stability and pull-in properties of the third-order type 2 analog PLLs are determined. Both the local and global stability conditions are derived. As a new idea, the harmonic balance method is used to derive the global stability conditions. That approach…

birth of oscillationselektroniset piirithold-in rangeglobal stabilityEgan conjecturethird-order PLLharmonic balance methodsäätöteoriavärähtelytdescribing functionsäätötekniikkalock-in rangephase-locked loopnonlinear analysispull-in rangetype 2 PLLmatemaattiset mallit
researchProduct

Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes

2021

Background: White adipose tissue (WAT) browning is a promising target for obesity prevention and treatment. Empagliflozin has emerged as an agent with weight-loss potential in clinical and in vivo studies, but the mechanisms underlying its effect are not fully understood. Here, we investigated whether empagliflozin could induce WAT browning and mitochondrial alterations in KK Cg-Ay/J (KKAy) mice, and explored the mechanisms of its effects.Methods: Eight-week-old male KKAy mice were administered empagliflozin or saline for 8 weeks and compared with control C57BL/6J mice. Mature 3T3-L1 adipocytes were treated in the presence or absence of empagliflozin. Mitochondrial biosynthesis, dynamics, a…

browningmedicine.medical_specialtyfusionChemistrytype 2 diabetes mellitusPhysiologyMFN2AMPKsodium-glucose co-transporter-2 inhibitorWhite adipose tissueMitochondrionThermogeninmitochondrial dynamicsmitochondriamedicine.anatomical_structureEndocrinologyMitochondrial biogenesisPhysiology (medical)Internal medicineBrown adipose tissueEmpagliflozinmedicineQP1-981Original ResearchFrontiers in Physiology
researchProduct

Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links.

2014

Diabetes and cancer represent two common, multifactorial, chronic and potentially fatal diseases, not infrequently co-diagnosed in the same patient. Epidemiological data demonstrate significant increases of the cancer incidence in patients with obesity and diabetes, which is more evident for certain site-specific cancers. Although there is increasing evidence that strongly indicates an augmented risk of cancer in diabetic patients, several confounding factors complicate the ability to precisely assess the risk. Mainly in insulin-resistant states (such as in type 2 diabetes mellitus and in metabolic syndrome), direct associations between obesity-related hyperinsulinemia and increasing circul…

business.industryGeneral NeuroscienceType 2 Diabetes MellitusCancerGeneral MedicineReviewmedicine.diseaseBioinformaticsmedicine.disease_causeObesityGeneral Biochemistry Genetics and Molecular Biologyinsulin-resistant stateanti-cancer drugdiabeteDiabetes mellitusanti-diabetic medicationmedicineHyperinsulinemiacancerGeneral Pharmacology Toxicology and PharmaceuticsMetabolic syndromeAdverse effectCarcinogenesisbusinessriskBiomedical reports
researchProduct

Long-Term Exposure to Transportation Noise and Risk for Type 2 Diabetes in a Nationwide Cohort Study from Denmark

2021

Background: Epidemiologic studies have linked transportation noise to increased morbidity and mortality, particularly for cardiovascular outcomes. However, studies investigating metabolic outcomes such as diabetes are limited and have focused only on noise exposures estimated for the loudest residential façade. Objectives: We aimed to examine the influence of long-term residential exposure to transportation noise at the loudest and quietest residential façades and the risk for type 2 diabetes. Methods: Road traffic and railway noise exposures (Lden) at the most and least exposed façades were estimated for all dwellings in Denmark during 1990–2017. Aircraft noise was estimated in 5-dB catego…

business.industryHealth Toxicology and MutagenesisResearchPublic Health Environmental and Occupational HealthType 2 diabetesEnvironmental Exposuremedicine.diseaseTerm (time)Cohort StudiesNoiseNoise TransportationEnvironmental healthmedicineDiabetes MellitusHumansbusinessCardiovascular outcomesCohort studyEnvironmental Health Perspectives
researchProduct

Diet Rich in Plant Protein May Prevent Type 2 Diabetes

2020

Purpose : The aim is to show the ideal protein quality and quantity and the dietary composition for the prevention and metabolic control of type 2 diabetes mellitus (T2DM). Introduction Although some reviews demonstrate the advantages of a diet with a higher protein intake, other reviews have observed that a diet high in carbohydrates, with low-glycaemic index carbohydrates and good fibre intake, is equally effective in improving insulin sensitivity. Methods Over 2831 articles were screened, and 24 from the last 5 years were analysed and summarised for this review, using the protein, diabetes and insulin glucose metabolic keywords in Pubmed in June 2019. Results Eleven studies demonstrate t…

business.industryInsulinmedicine.medical_treatmentType 2 Diabetes MellitusType 2 diabetesmedicine.diseasePlant proteinMetabolic control analysisDiabetes mellitusmedicineFood scienceMetabolic syndromebusinessProtein qualityProceedings of The 1st International Electronic Conference on Plant Science
researchProduct

Cardiorespiratory Fitness Estimation Based on Heart Rate and Body Acceleration in Adults With Cardiovascular Risk Factors : Validation Study

2022

Publisher Copyright: © Antti-Pekka E Rissanen, Mirva Rottensteiner, Urho M Kujala, Jari L O Kurkela, Jan Wikgren, Jari A Laukkanen. Originally published in JMIR Cardio (https://cardio.jmir.org), 25.10.2022. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cardio, is properly cited. The complete bibliographic information, a link to the original publication on https://cardio.jmir.org, as well as this copyright and license information must be included. Background: C…

cardiorespiratory fitnesshypertensiondiabetesheart rate variabilityHealth Informaticsriskitekijätwearable technology3121 General medicine internal medicine and other clinical medicineterveysvaikutuksetsydän- ja verisuonitauditkohonnut verenpainetype 2 diabetespuettava teknologiaCardiology and Cardiovascular Medicineaikuistyypin diabetesmetabolinen oireyhtymäcardiopulmonary exercise test
researchProduct

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

2010

The ADA and the EASD recently published a consensus statement for the medical management of hyperglycaemia in patients with type 2 diabetes. The authors advocate initial treatment with metformin monotherapy and lifestyle modification, followed by addition of basal insulin or a sulfonylurea if glycaemic goals are not met (tier 1 recommendations). All other glucose-lowering therapies are relegated to a secondary (tier 2) status and only recommended for selected clinical settings. In our view, this algorithm does not offer physicians and patients the appropriate selection of options to individualise and optimise care with a view to sustained control of blood glucose and reduction both of diabe…

cardiovascular riskGlucose-lowering therapyEndocrinology Diabetes and MetabolismeducationSocieties Medical/standardsMEDLINE10265 Clinic for Endocrinology and DiabetologyHypoglycemic Agents/therapeutic use610 Medicine & healthType 2 diabetesHyperglycemia/drug therapyLifestyle modificationRisk FactorsDiabetes mellitusTier 2 networkADA Consensus StatementmedicineInternal MedicineInitial treatmentHyperglycaemiaHumansIn patientFor Debatealgorithmbusiness.industrynutritional and metabolic diseasesType 2 diabetesmedicine.diseaseCardiovascular riskUnited StatesMetforminEASD consensus statementglucose-lowering therapyAlgorithmEurope2712 Endocrinology Diabetes and Metabolism2724 Internal Medicine*AlgorithmsDiabetes Mellitus Type 2/complications/*drug therapytype 2 diabetesbusinessAlgorithmCardiovascular Diseases/prevention & controlhyperglycaemiamedicine.drug
researchProduct

Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes

2022

The current management of Type 2 Diabetes Mellitus (T2DM) includes incretin-based treatments able to enhance insulin secretion and peripheral insulin sensitivity as well as improve body mass, inflammation, plasma lipids, blood pressure, and cardiovascular outcomes. Dietary Free Fatty Acids (FFA) regulate metabolic and anti-inflammatory processes through their action on incretins. Selective synthetic ligands for FFA1-4 receptors have been developed as potential treatments for T2DM. To comprehensively review the available evidence for the potential role of FFA receptor agonists in the treatment of T2DM, we performed an electronic database search assessing the association between FFAs, T2DM, i…

cardiovascular riskMedicine (General)Cardiovascular risk Free fatty acidsGLP-1 Incretins Metabolism Type 2 diabetes Fatty Acids Nonesterified Humans Diabetes Mellitus Type 2 Insulin Resistanceendocrine system diseasesfree fatty acidsType 2 diabetesReviewGeneral MedicineFatty Acids NonesterifiedR5-920Diabetes Mellitus Type 2HumansInsulin ResistanceGLP-1metabolismincretinsMedicina
researchProduct